Search filters

List of works by Gilles Peytavin

A new mechanism of resistance of HIV-2 to integrase inhibitors: a 5 amino-acids insertion in the integrase C-terminal domain

article

Absence of HIV-1 shedding in male genital tract after 1 year of first-line lopinavir/ritonavir alone or in combination with zidovudine/lamivudine

scientific article

Absence of association between MDR1 genetic polymorphisms, indinavir pharmacokinetics and response to highly active antiretroviral therapy

scientific article

Adherence to antiretroviral therapy and outcomes in HIV-infected patients enrolled in an induction/maintenance randomized trial.

scientific article

Adherence to antiretroviral therapy assessed by drug level monitoring and self-report in cameroon

scientific article published in June 2008

Amprenavir inhibitory quotient and virological response in human immunodeficiency virus-infected patients on an amprenavir-containing salvage regimen without or with ritonavir

scientific article published on February 2002

Antihepatitis C virus treatments for HIV-hepatitis C virus coinfected cirrhotic patients: a need to look beyond the sustained viral response

scientific article published on September 2015

Antiretroviral therapy with a twice-daily regimen containing 400 milligrams of indinavir and 100 milligrams of ritonavir in human immunodeficiency virus type 1-infected women during pregnancy

scientific article published on 4 February 2008

Antiretroviral-Experienced HIV-1-Infected Patients Treated with Maraviroc: Factors Associated with Virological Response

scientific article published on 17 December 2014

Association of dolutegravir and rilpivirine, enhanced by foscarnet induction, in effective salvage antiretroviral therapy

scientific article published on 14 May 2014

Association of the ANRS-12126 male circumcision project with HIV levels among men in a South African township: evaluation of effectiveness using cross-sectional surveys

scientific article

Atazanavir: a novel inhibitor of HIV-protease in haemodialysis

scientific article

Bariatric surgery in HIV patients: experience of an Obesity Reference Center in France

scientific article published on 14 September 2017

Benefit of therapeutic drug monitoring of protease inhibitors in HIV-infected patients depends on PI used in HAART regimen--ANRS 111 trial

scientific article

Bidirectional Transfer of Raltegravir in an Ex Vivo Human Cotyledon Perfusion Model

scientific article published on February 2016

Biomarker-Based HIV Incidence in a Community Sample of Men Who Have Sex with Men in Paris, France ⬇️

scientific article published on June 29, 2012

Budget impact of antiretroviral therapy in a French clinic cohort

scientific article published on 18 March 2017

CD4 cell recovery in treated HIV-2-infected adults is lower than expected: results from the French ANRS CO5 HIV-2 cohort

article

Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates

scientific article published on 6 August 2015

Chronic hepatitis E in HIV/HBV coinfected patient: lack of power of sofosbuvir-ribavirin

scientific article published on June 2017

Chronic hepatitis E in a heart transplant patient: sofosbuvir and ribavirin regimen not fully effective.

scientific article

Clinical activity of lenalidomide in visceral human immunodeficiency virus-related Kaposi sarcoma

scientific article published on November 2013

Clinical and resistance consequences of misquantification of plasma and cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) RNA in samples from an HIV-1 subtype G-infected patient

scientific article published on 16 September 2009

Clinical validation of atazanavir/ritonavir genotypic resistance score in protease inhibitor-experienced patients

scientific article published in January 2006

Clinically relevant interpretation of genotype and relationship to plasma drug concentrations for resistance to saquinavir-ritonavir in human immunodeficiency virus type 1 protease inhibitor-experienced patients

scientific article

Clinically relevant interpretation of genotype for resistance to abacavir

scientific article published in August 2003

Comparative selection of the K65R and M184V/I mutations in human immunodeficiency virus type 1-infected patients enrolled in a trial of first-line triple-nucleoside analog therapy (Tonus IMEA 021).

scientific article published on August 2005

Contribution and limit of the model of perfused cotyledon to the study of placental transfer of drugs. Example of a protease inhibitor of HIV: nelfinavir

scientific article published on 20 September 2009

Current status and future prospects of therapeutic drug monitoring and applied clinical pharmacology in antiretroviral therapy

scientific article

Cyclosporine monitoring in renal transplant recipients with induction therapy: C2 levels in patients monitored on C0.

scientific article published in February 2006

Deleterious pharmacokinetic interaction between bexarotene and efavirenz ⬇️

scientific article published on September 10, 2010

Direct quantification of cell-associated HIV DNA in isolated rectal and blood memory CD4 T cells revealed their similar and low infection levels in long-term treated HIV-infected patients

scientific article published in March 2013

Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy

article

Dolutegravir in HIV-2-Infected Patients With Resistant Virus to First-line Integrase Inhibitors From the French Named Patient Program

scientific article published on 17 February 2015

Dynamics of gag-pol minority viral populations in naive HIV-1-infected patients failing protease inhibitor regimen ⬇️

scientific article published on November 13, 2011

E17A mutation in HIV-1 Vpr confers resistance to didanosine in association with thymidine analog mutations

scientific article published on 25 November 2011

Early upper digestive tract side effects of zidovudine with tenofovir plus emtricitabine in West African adults with high CD4 counts

scientific article published on 30 April 2013

Effect of antiretroviral drugs on the quality of semen

scientific article published in August 2011

Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine or stavudine, each in combination with lamivudine and indinavir

scientific article published in December 2002

Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial

scientific article published on July 2004

Efficacy and safety of once-daily ritonavir-boosted atazanavir or darunavir in combination with a dual nucleos(t)ide analogue backbone in HIV-1-infected combined ART (cART)-naive patients with severe immunosuppression: a 48 week, non-comparative, ra

scientific article

Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study.

scientific article published on 6 May 2009

Efficacy and safety of ritonavir/indinavir 100/400 mg twice daily in combination with two nucleoside analogues in antiretroviral treatment-naive HIV-infected individuals.

scientific article published in December 2003

Efficacy and safety of tenofovir double-dose in treatment-experienced HIV-infected patients: the TENOPLUS study

article

Efficacy of a twice-daily antiretroviral regimen containing 100 mg ritonavir/400 mg indinavir in HIV-infected patients

scientific article

Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136.

scientific article

Efficacy, safety, and pharmacokinetics of once-daily boosted darunavir in pretreated HIV-infected patients

scientific article published on 11 March 2013

Erratum for Mandelbrot et al., placental transfer of rilpivirine in an ex vivo human cotyledon perfusion model

scientific article published on September 2015

Erythrocyte and plasma ribavirin concentrations in the assessment of early and sustained virological responses to pegylated interferon-alpha 2a and ribavirin in patients coinfected with hepatitis C virus and HIV.

scientific article published on 5 March 2012

Evaluation of four tenofovir-containing regimens as first-line treatments in Cameroon and Senegal: the ANRS 12115 DAYANA Trial

scientific article published on 23 August 2013

Evolution of human immunodeficiency virus type 1 (HIV-1) resistance mutations in nonnucleoside reverse transcriptase inhibitors (NNRTIs) in HIV-1-infected patients switched to antiretroviral therapy without NNRTIs

scientific article published on January 2004

Evolution of protease and reverse transcriptase inhibitor resistance-associated mutations in HIV-1-infected protease inhibitor-treated patients with persistent low viraemia.

scientific article

Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients

article

Factors associated with the selection of mutations conferring resistance to protease inhibitors (PIs) in PI-experienced patients displaying treatment failure on darunavir

scientific article

Final analysis of the Trilège induction-maintenance trial: results at 18 months

scientific article published in March 2002

First line raltegravir/emtricitabine/tenofovir combination in HIV-2 infection: phase 2 non-comparative trial (ANRS 159 HIV-2).

scientific article published on 24 March 2018

First-line therapy with LPV/r vs NVP and 2 NRTIs in a developing country: W144 of a randomized trial.

scientific article published on 23 May 2014

Foscarnet, zidovudine and dolutegravir combination efficacy and tolerability for late stage HIV salvage therapy: A case-series experience

scientific article

Gender Differences in Adherence and Response to Antiretroviral Treatment in the Stratall Trial in Rural District Hospitals in Cameroon

scientific article

Generic antiretroviral drugs in developing countries: friends or foes?

scientific article published in February 2014

Genotypic determinants of the virological response to tenofovir disoproxil fumarate in nucleoside reverse transcriptase inhibitor-experienced patients

scientific article published in June 2004

Genotypic inhibitory quotient as predictor of virological response to ritonavir-amprenavir in human immunodeficiency virus type 1 protease inhibitor-experienced patients

scientific article

Genotypic resistance analyses in nucleoside-pretreated patients failing an indinavir containing regimen: results from a randomized comparative trial: (Novavir ANRS 073).

scientific article published in June 2005

Genotypic resistance profiles of HIV-2-treated patients in West Africa

scientific article

Good response to lopinavir/ritonavir-containing antiretroviral regimens in antiretroviral-naive HIV-2-infected patients

scientific article

HIV and antiretroviral drug distribution in plasma and fat tissue of HIV-infected patients with lipodystrophy

scientific article published in December 2002

HIV drug resistance after the use of generic fixed-dose combination stavudine/lamivudine/nevirapine as standard first-line regimen

scientific article published on November 2007

HIV-1 group O resistance pathway with raltegravir is similar to HIV-1 group M.

scientific article published in June 2015

HIV-1 intermittent viraemia in patients treated by non-nucleoside reverse transcriptase inhibitor-based regimen

scientific article published in July 2005

HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report

scientific article published on 9 December 2015

HIV-1-infected patients from the French National Observatory experiencing virological failure while receiving enfuvirtide

scientific article published on 13 June 2008

High Rates of Baseline Drug Resistance and Virologic Failure Among ART Naïve HIV-Infected Children in Mali

scientific article published on 13 February 2017

High efficacy of first-line ART in a West African cohort, assessed by dried blood spot virological and pharmacological measurements

scientific article published on 20 July 2016

High indinavir plasma concentrations in HIV-positive patients co-infected with hepatitis B or C virus treated with low doses of indinavir and ritonavir (400/100 mg twice a day) plus two nucleoside reverse transcriptase inhibitors

scientific article published in May 2003

High prevalence of antiretroviral drug resistance among HIV-1-untreated patients in Guinea-Conakry and in Niger

scientific article published in January 2011

High variability of indinavir and nelfinavir pharmacokinetics in HIV-infected patients with a sustained virological response on highly active antiretroviral therapy

scientific article published in January 2005

High viral loads among HIV-positive MSM attending gay venues: implications for HIV transmission

scientific article

High virological suppression regardless of the genotypic susceptibility score after switching to a dolutegravir-based regimen: week 48 results in an observational cohort.

scientific article

Highly multidrug-resistant HIV: clonal analysis and therapeutic strategies

scientific article published on 19 July 2013

Human immunodeficiency virus (HIV) Type 1 reverse transcriptase resistance mutations in hepatitis B virus (HBV)-HIV-coinfected patients treated for HBV chronic infection once daily with 10 milligrams of adefovir dipivoxil combined with lamivudine

scientific article published on May 2002

Impact of hepatitis C and liver fibrosis on antiretroviral plasma drug concentrations in HIV-HCV co-infected patients: the HEPADOSE study

scientific article published on 2 September 2010

Impact of lopinavir/ritonavir use on antiretroviral resistance in recent clinical practice

scientific article published on 25 June 2012

Impact of nevirapine (NVP) plasma concentration on selection of resistant virus in mothers who received single-dose NVP to prevent perinatal human immunodeficiency virus type 1 transmission and persistence of resistant virus in their infected childr

scientific article

Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study

scientific article published on 8 January 2017

In vitro phenotypic susceptibility of HIV-2 clinical isolates to CCR5 inhibitors

scientific article published on 7 November 2011

In vitro phenotypic susceptibility of human immunodeficiency virus type 2 clinical isolates to protease inhibitors

scientific article published on 28 January 2008

In-vitro phenotypic susceptibility of HIV-1 'non-B' integrase inhibitors naive clinical isolates to dolutegravir and raltegravir

scientific article published on November 2013

Indinavir plasma concentration and adherence score are codeterminant of early virologic response in HIV-infected patients of the APROCO cohort

scientific article published in February 2005

Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial

scientific article

Intermittent viremia during first-line, protease inhibitors-containing therapy: significance and relationship with drug resistance

scientific article published in May 2005

Interruption of nonnucleoside reverse transcriptase inhibitor (NNRTI) therapy for 2 months has no effect on levels of human immunodeficiency virus type 1 in plasma of patients harboring viruses with mutations associated with resistance to NNRTIs

scientific article

Is phosphatemia the best tool to monitor renal tenofovir toxicity?

scientific article published in October 2007

Lack of indinavir-associated nephrological complications in HIV-infected adults (predominantly women) with high indinavir plasma concentration in Abidjan, Côte d'Ivoire

scientific article published on January 2007

Less-drug regimen including atazanavir in maintenance treatment of HIV infection: how, who, when, why?

scientific article published on 21 September 2016

Letter. In vitro phenotypic susceptibility to nucleoside reverse transcriptase inhibitors of HIV-2 isolates with the Q151M mutation in the reverse transcriptase gene

scientific article published in January 2005

Level of viral suppression and the cascade of HIV care in a South African semi-urban setting in 2012.

scientific article published on 9 May 2016

Long-term safety, effectiveness and quality of a generic fixed-dose combination of nevirapine, stavudine and lamivudine

scientific article published in March 2007

Lopinavir/ritonavir population pharmacokinetics in neonates and infants

scientific article

Low frequency of intermittent HIV-1 semen excretion in patients treated with darunavir-ritonavir at 600/100 milligrams twice a day plus two nucleoside reverse transcriptase inhibitors or monotherapy

scientific article published on 16 August 2010

Low risk of nevirapine resistance mutations in the prevention of mother-to-child transmission of HIV-1: Agence Nationale de Recherches sur le SIDA Ditrame Plus, Abidjan, Cote d'Ivoire

scientific article published on 11 January 2006

Low trough plasma concentrations of nevirapine associated with virologic rebounds in HIV-infected patients who switched from protease inhibitors

scientific article published on 15 February 2005

Low-level HIV-1 viraemia in patients on HAART: risk factors and management in clinical practice

scientific article published on 28 April 2015

Maraviroc Intensification of Stable Antiviral Therapy in HIV-1–Infected Patients With Poor Immune Restoration

article

Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 study

scientific article published on 16 February 2014

Maraviroc-containing regimen suppresses HIV replication in the cerebrospinal fluid of patients with neurological symptoms

scientific article published on August 2010

Mechanisms of early virologic failure in antiretroviral-naive patients starting protease inhibitor-containing regimens: the APROVIR Study

scientific article published on 23 October 2002

Mitochondrial and metabolic effects of nucleoside reverse transcriptase inhibitors (NRTIs) in mice receiving one of five single- and three dual-NRTI treatments

scientific article published on November 2003

Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro

scientific article published on 28 January 2008

Mutations associated with virological response to darunavir/ritonavir in HIV-1-infected protease inhibitor-experienced patients

scientific article published on 15 January 2009

Nevirapine once daily: pharmacology, metabolic profile and efficacy data of the new extended-release formulation ⬇️

scientific article published on March 20, 2011

Nevirapine or lamivudine plus stavudine and indinavir: examples of 2-class versus 3-class regimens for the treatment of human immunodeficiency virus type 1.

scientific article published on 15 October 2002

Nevirapine-raltegravir combination, an NRTI and PI/r sparing regimen, as maintenance antiretroviral therapy in virologically suppressed HIV-1-infected patients

scientific article published on 22 October 2013

No benefit of a structured treatment interruption based on genotypic resistance in heavily pretreated HIV-infected patients

scientific article published on October 2005

Nucleoside reverse transcriptase inhibitor-sparing regimen (nonnucleoside reverse transcriptase inhibitor + protease inhibitor) was more likely associated with resistance comparing to nonnucleoside reverse transcriptase inhibitor or protease inhibit

scientific article published in July 2009

On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection

scientific article

Once-a-day highly active antiretroviral therapy in treatment-naive HIV-1-infected adults in Senegal

scientific article published in May 2003

Once-daily administration of antiretrovirals: pharmacokinetics of emerging therapies

scientific article published on January 2003

Once-daily dosing of saquinavir soft-gel capsules and ritonavir combination in HIV-1-infected patients (IMEA015 study).

scientific article

Penetration and antiviral efficacy of total and unbound maraviroc, raltegravir and rilpivirine in both female and male genital fluids from HIV-positive patients receiving regimens containing these antiretrovirals

scientific article

Penetration of enfuvirtide, tenofovir, efavirenz, and protease inhibitors in the genital tract of HIV-1-infected men.

scientific article published in September 2004

Persistent high nevirapine blood level with DRESS syndrome 12 days after interruption of antiretroviral therapy

scientific article

Persistent viremia in human immunodeficiency virus/hepatitis B coinfected patients undergoing long-term tenofovir: virological and clinical implications

scientific article published on 20 June 2014

Pharmacokinetic and pharmacodynamic interaction between grapefruit juice and halofantrine

scientific article

Pharmacokinetics and Safety of Darunavir/Ritonavir in HIV-Infected Pregnant Women

scientific article published on January 2017

Pharmacokinetics and dosage adjustment of rifabutin in a haemodialysis patient

scientific article published in March 2002

Pharmacokinetics of the treatment switch from efavirenz to nevirapine

scientific article published in June 2010

Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C.

scientific article

Pharmacokinetics, safety and efficacy of ritonavir-boosted atazanavir (300/100 mg once daily) in HIV-1-infected pregnant women

scientific article published on 20 January 2015

Phase II Trial of Lenalidomide in HIV-Infected Patients with Previously Treated Kaposi's Sarcoma: Results of the ANRS 154 Lenakap Trial

scientific article published on 12 July 2016

Placental transfer of darunavir in an ex vivo human cotyledon perfusion model

scientific article

Placental transfer of elvitegravir and cobicistat in an ex-vivo human cotyledon double perfusion model

scientific article published on 2 November 2017

Placental transfer of enfuvirtide in the ex vivo human placenta perfusion model

scientific article

Placental transfer of rilpivirine in an ex vivo human cotyledon perfusion model

scientific article

Plasma concentrations of maraviroc and raltegravir after dual therapy in patients with long-term suppressed viraemia: ROCnRAL ANRS 157 study: Figure 1

scientific article published on 26 April 2015

Plasma levels of indinavir and nelfinavir at time of virologic response may have a different impact on the risk of further virologic failure in HIV-infected patients

scientific article

Poor Efficacy and Tolerability of Stavudine, Didanosine, and Efavirenz-based Regimen in Treatment-Naive Patients in Senegal

scientific article published on 09 October 2007

Poor efficacy and tolerability of stavudine, didanosine, and efavirenz-based regimen in treatment-naive patients in Senegal

scientific article

Population pharmacokinetics of Rilpivirine in HIV-1-infected patients treated with the single-tablet regimen rilpivirine/tenofovir/emtricitabine

scientific article

Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models

scientific article published on 31 October 2015

Predictors of the virological response to a change in the antiretroviral treatment regimen in HIV-1-infected patients enrolled in a randomized trial comparing genotyping, phenotyping and standard of care (Narval trial, ANRS 088).

scientific article published in October 2003

Predictors of virologic response to ritonavir-boosted protease inhibitors

scientific article

Quasispecies analysis and in vitro susceptibility of HBV strains isolated from HIV–HBV-coinfected patients with delayed response to tenofovir

article

Quasispecies variant dynamics during emergence of resistance to raltegravir in HIV-1-infected patients

scientific article published on 16 February 2009

Raltegravir as functional monotherapy leads to virological failure and drug resistance in highly treatment-experienced HIV-infected patients

scientific article published in July 2010

Raltegravir concentrations in the genital tract of HIV-1-infected women treated with a raltegravir-containing regimen (DIVA 01 study)

scientific article

Raltegravir has no residual antiviral activity in vivo against HIV-1 with resistance-associated mutations to this drug

scientific article published on 27 August 2009

Rapid selection and archiving of mutation E157Q in HIV-1 DNA during short-term low-level replication on a raltegravir-containing regimen

scientific article

Relationship between levels of indinavir in hair and virologic response to highly active antiretroviral therapy

scientific article published in October 2002

Resistance profiles observed in virological failures after 24 weeks of amprenavir/ritonavir containing regimen in protease inhibitor experienced patients

scientific article published in September 2004

Resistant minority species are rarely observed in patients on darunavir/ritonavir monotherapy.

scientific article

Ribavirin and abacavir drug interaction in HIV–HCV coinfected patients ⬇️

scientific article published on November 13, 2012

Role of HIV-1 minority populations on resistance mutational pattern evolution and susceptibility to protease inhibitors

scientific article published in January 2006

Rosuvastatin versus pravastatin in dyslipidemic HIV-1-infected patients receiving protease inhibitors: a randomized trial

scientific article published in January 2010

Selection of K65R mutation in HIV-2-infected patients receiving tenofovir-containing regimen.

scientific article published in August 2004

Selection of a rare resistance profile in an HIV-1-infected patient exhibiting a failure to an antiretroviral regimen including tenofovir DF.

scientific article published in March 2005

Selection of the Q148R integrase inhibitor resistance mutation in a failing raltegravir containing regimen

scientific article

Serious neuropsychiatric adverse effects in a hepatitis C virus/hepatitis B virus/HIV-coinfected patient receiving bosentan and telaprevir

scientific article published on 20 January 2013

Severe cardiac toxicity due to halofantrine: importance of underlying heart disease.

scientific article

Severe insomnia related to high concentrations of raltegravir ⬇️

scientific article published on March 13, 2011

Short communication: Prevalence of HIV-1 transmitted drug resistance in Liberia

scientific article published on 14 July 2014

Sialolithiasis in an HIV-1-infected patient treated with atazanavir/ritonavir monotherapy ⬇️

scientific article published on November 1, 2012

Single-dose pharmacokinetics and pharmacodynamics of oral tenofovir and emtricitabine in blood, saliva and rectal tissue: a sub-study of the ANRS IPERGAY trial

scientific article published on 28 September 2016

Stability of ritonavir soft capsule formulation in patients with and without a refrigerator at home in Côte d'Ivoire

scientific article published in November 2006

Successful anti-hepatitis C virus therapy with telaprevir in an HIV/hepatitis C virus co-infected patient with a severe recurrence of hepatitis C virus infection on the liver graft

scientific article published on October 2013

Suspected interaction between sorafenib and HAART in an HIV-1 infected patient: a case report

scientific article published in January 2011

Switch as maintenance to elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate: week 48 results in a clinical cohort

scientific article published on 10 February 2017

Switch to Rilpivirine/Emtricitabine/Tenofovir Single-Tablet Regimen of Human Immunodeficiency Virus-1 RNA-Suppressed Patients, Agence Nationale de Recherches sur le SIDA et les Hépatites Virales CO3 Aquitaine Cohort, 2012-2014

scientific article published on January 2015

Switching to darunavir/ritonavir 800/100 mg once-daily containing regimen maintains virological control in fully suppressed pre-treated patients infected with HIV-1.

scientific article published on 28 September 2012

Tenofovir plasma concentrations related to estimated glomerular filtration rate changes in first-line regimens in African HIV-infected patients: ANRS 12115 DAYANA substudy

scientific article published on 11 January 2015

Tenofovir/probenecid combination in HIV/HBV-coinfected patients: how to escape Fanconi syndrome recurrence?

scientific article published in April 2010

The detection of non-adherence by self-administered questionnaires can be optimized by protease inhibitor plasma concentration determination

scientific article

The hairy-print for levamisole-induced vasculitis: Figure 1 ⬇️

scientific article published on August 8, 2012

Tipranavir-ritonavir genotypic resistance score in protease inhibitor-experienced patients

scientific article published on 14 July 2008

Transmitted drug resistance in French HIV-2-infected patients

scientific article

Tubulopathy consecutive to tenofovir-containing antiretroviral therapy in two patients infected with human immunodeficiency virus-1.

scientific article

Use of PCR Signal and Therapeutic Drug Monitoring in a Switch Cohort Study to Tenofovir/Emtricitabine/Rilpivirine: A W96 Follow-Up

scientific article

Usefulness of therapeutic drug monitoring of antiretrovirals in routine clinical practice

scientific article published in July 2004

Using pharmacokinetic and viral kinetic modeling to estimate the antiviral effectiveness of telaprevir, boceprevir, and pegylated interferon during triple therapy in treatment-experienced hepatitis C virus-infected cirrhotic patients

scientific article

Virologic outcome after switching from a nucleoside reverse transcriptase inhibitor to tenofovir in patients with undetectable HIV-1 RNA plasma level

scientific article

Virological and immunological response to HAART regimen containing integrase inhibitors in HIV-2-infected patients

article

Virological and pharmacological factors associated with virological response to salvage therapy after an 8-week of treatment interruption in a context of very advanced HIV disease (GigHAART ANRS 097).

scientific article published in November 2005

Virological and pharmacological parameters predicting the response to lopinavir-ritonavir in heavily protease inhibitor-experienced patients

scientific article

Virological factors associated with outcome of dual maraviroc/raltegravir therapy (ANRS-157 trial).

scientific article

Virological failure of patients on maraviroc-based antiretroviral therapy

scientific article published on 19 February 2015

Virological outcome at week 48 of three recommended first-line regimens using ultrasensitive viral load and plasma drug assay

scientific article published on 19 June 2014

[CCR5 antagonists: a new class of antiretrovirals].

scientific article

Paulina is supported by:

About Paulina

Help